MedTrace Logo

Clinical Outcomes Study of the Nexel Total Elbow

NCT02469662 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2025-10-29

No results posted yet for this study

Summary

The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total Elbow when used in primary or revision total elbow replacement.

Conditions

  • Elbow Joint Destruction
  • Post-traumatic Lesions
  • Ankylosed Joints
  • Advanced Rheumatoid Arthritis
  • Joint Instability or Loss of Motion
  • Acute Comminuted Articular Fracture of Elbow Joint Surfaces
  • Bone Loss Contributing to Elbow Instability
  • Bilateral Ankylosis From Causes Other Than Active Sepsis
  • Post-traumatic Arthritis
  • Degenerative Arthritis

Interventions

DEVICE

Nexel Total Elbow

Nexel Total Elbow used in primary or revision total elbow arthroplasty

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Hillary Overholser, MS · Zimmer Biomet

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2035-12-31
Completion
2036-12-31
FDA Device
Yes

Countries

  • United States
  • Australia
  • Finland
  • France
  • Germany
  • Italy
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02469662 on ClinicalTrials.gov